Find uplifting stories about heroes, innovations, and solutions
6 results for "psychedelic therapy"
A groundbreaking clinical trial shows one dose of the psychedelic DMT significantly reduced depression symptoms for up to six months. For millions who haven't found relief from traditional treatments, this research opens a promising new door.
A groundbreaking psilocybin-based therapy just moved closer to becoming the first psychedelic treatment approved for severe depression. Two major clinical trials showed the therapy significantly improved symptoms with just one or two doses.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A clinical trial found that one dose of DMT, a natural psychedelic compound, significantly reduced depression symptoms for up to three months. The short treatment session could make mental health care more accessible for millions who don't respond to traditional antidepressants.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
New research shows psychedelics like psilocybin and MDMA could help people with PTSD recover in hours instead of months by actually rewiring trauma-affected brain systems. Clinical trials reveal 67% of patients no longer met PTSD criteria after MDMA-assisted therapy, offering hope to 12 million Americans struggling with the condition.